# Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders

> **NCT05405686** · PHASE4 · WITHDRAWN · sponsor: **CRG UZ Brussel**

## Conditions studied

- Poor Response to Ovulation Induction

## Interventions

- **DRUG:** Lutropin alfa
- **DRUG:** Follitropin alfa
- **DIAGNOSTIC_TEST:** Endometrial biopsy

## Key facts

- **NCT ID:** NCT05405686
- **Lead sponsor:** CRG UZ Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-05-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn due to practical reasons
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05405686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05405686, "Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05405686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*